Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 2
1961 6
1962 3
1963 4
1964 4
1965 7
1966 4
1967 3
1968 5
1969 6
1970 5
1971 3
1972 8
1973 4
1974 7
1975 12
1976 13
1977 8
1978 9
1979 3
1980 6
1981 12
1982 8
1983 14
1984 14
1985 13
1986 6
1987 19
1988 26
1989 18
1990 21
1991 21
1992 21
1993 39
1994 36
1995 50
1996 43
1997 55
1998 50
1999 50
2000 65
2001 46
2002 65
2003 66
2004 38
2005 46
2006 32
2007 36
2008 38
2009 48
2010 51
2011 62
2012 59
2013 56
2014 65
2015 55
2016 61
2017 63
2018 46
2019 49
2020 58
2021 63
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

1,690 results
Results by year
Filters applied: . Clear all
Page 1
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma.
Goyal L, Shi L, Liu LY, Fece de la Cruz F, Lennerz JK, Raghavan S, Leschiner I, Elagina L, Siravegna G, Ng RWS, Vu P, Patra KC, Saha SK, Uppot RN, Arellano R, Reyes S, Sagara T, Otsuki S, Nadres B, Shahzade HA, Dey-Guha I, Fetter IJ, Baiev I, Van Seventer EE, Murphy JE, Ferrone CR, Tanabe KK, Deshpande V, Harding JJ, Yaeger R, Kelley RK, Bardelli A, Iafrate AJ, Hahn WC, Benes CH, Ting DT, Hirai H, Getz G, Juric D, Zhu AX, Corcoran RB, Bardeesy N. Goyal L, et al. Among authors: hirai h. Cancer Discov. 2019 Aug;9(8):1064-1079. doi: 10.1158/2159-8290.CD-19-0182. Epub 2019 May 20. Cancer Discov. 2019. PMID: 31109923 Free PMC article.
Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma.
Takahashi H, Tada Y, Saotome T, Akazawa K, Ojiri H, Fushimi C, Masubuchi T, Matsuki T, Tani K, Osamura RY, Hirai H, Yamada S, Kawakita D, Miura K, Kamata SE, Nagao T. Takahashi H, et al. Among authors: hirai h. J Clin Oncol. 2019 Jan 10;37(2):125-134. doi: 10.1200/JCO.18.00545. Epub 2018 Nov 19. J Clin Oncol. 2019. PMID: 30452336 Clinical Trial.
A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma.
Fushimi C, Tada Y, Takahashi H, Nagao T, Ojiri H, Masubuchi T, Matsuki T, Miura K, Kawakita D, Hirai H, Hoshino E, Kamata S, Saotome T. Fushimi C, et al. Among authors: hirai h. Ann Oncol. 2018 Apr 1;29(4):979-984. doi: 10.1093/annonc/mdx771. Ann Oncol. 2018. PMID: 29211833 Free PMC article. Clinical Trial.
Rapamycin activates mammalian microautophagy.
Sato M, Seki T, Konno A, Hirai H, Kurauchi Y, Hisatsune A, Katsuki H. Sato M, et al. Among authors: hirai h. J Pharmacol Sci. 2019 Jun;140(2):201-204. doi: 10.1016/j.jphs.2019.05.007. Epub 2019 May 24. J Pharmacol Sci. 2019. PMID: 31178328 Free article.
1,690 results